News Daily News No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits Michael O'Riordan July 14, 2025
News Conference News AHA 2024 Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY Shelley Wood November 17, 2024
Presentation AHA 2024 Routine spironolactone in Acute Myocardial Infarction, results from the CLEAR SYNERGY OASIS 9 trial Presenter: Sanjit S Jolly November 17, 2024
News Conference News TCT 2024 Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows Michael O'Riordan October 29, 2024
News Daily News Observational Study Supports Continuing Oral Anticoagulation During PCI Michael O'Riordan April 06, 2021
News Daily News Early Revascularization in NSTEMI Linked to Lower Mortality: AHRQ Analysis Michael O'Riordan August 20, 2020
News Conference News AHA 2019 No Benefit of Colchicine in All-Comers PCI Shelley Wood November 17, 2019
News Conference News ACC 2019 SAFARI Surprise: No Survival or Bleeding Advantage With Radial Over Femoral Access in STEMI Michael O'Riordan March 18, 2019
News Daily News Aspiration Thrombectomy on the Decline as New Study Affirms No Benefit in STEMI Michael O'Riordan January 15, 2019
News Daily News Cancelled Cath Lab Activations and Timely Reperfusion: A ‘Balancing Act’ Michael O'Riordan August 21, 2018
News Conference News EuroPCR 2017 Transradial PCI in ACS Reduces Risk of Acute Kidney Injury Michael O'Riordan May 18, 2017
News Daily News High-Volume Transradial PCI Centers Do Not Lose Femoral Skills: BCIS Registry Michael O'Riordan February 17, 2017
News Daily News Meta-analysis Affirms Lack of Benefit With Routine Thrombus Aspiration for STEMI Todd Neale December 15, 2016
News Daily News Meta-análisis confirma la ausencia de beneficios de la aspiración rutinaria del trombo para el tratamiento del STEMI Todd Neale December 15, 2016
News Daily News Heavy Burden of Residual Thrombus After Thrombectomy Signals Worse Primary PCI Results Todd Neale October 03, 2016
News Features The Bioresorbable Stent Story So Far: What Promise? What Price? Michael O'Riordan August 17, 2016